HAUPPAUGE, NY / ACCESSWIRE / May 24, 2023 / Botannis Labs, Inc., a leading provider of analytical testing services for the nutraceutical and pharmaceutical industries, is excited to announce the opening of its new testing facility in Hauppauge, Long Island, NY. The facility will provide comprehensive testing services, offering the industry’s highest level of expertise, utilizing state-of-the-art equipment and quality procedures.
We are proud to announce that the New York State Department of Health’s Bureau of Narcotic Enforcement has awarded Botannis with a Class 8 Analytical Laboratory license to handle and test controlled substances – a vital certification that permits Botannis to provide critical services to the supply chain.
In addition, Botannis offers regulatory support for our clients’ quality systems compliant with the Food and Drug Administration (FDA) and Good Manufacturing Practices (cGMP). The company now offers a comprehensive range of services that includes dietary supplement, drug, and cosmetic label reviews as well as stability testing, method development, product formulation, and evaluation and design of Standard Operating Procedures (SOPs). Botannis is able to efficiently and cost-effectively navigate the increasingly rigid and ever-changing requirements of consumer product quality and safety.
Read full press release here.